Multi-active biologics = multiple benefits
A multi-active biologic is a therapeutic that includes multiple factors that can influence a variety of biological pathways. Unlike traditional drugs that typically target only one specific cell component, multi-active biologics can engage several signaling complexes simultaneously, including those of the immune system.
Most diseases are driven by numerous biological factors that are too intricate to treat with a single drug. By targeting diseases with multi-active therapeutics, there is a greater opportunity to address the cellular complexities of disease.
IMM01-STEM
Immunis developed a novel method to grow human cells for clinical use and direct them to become highly pure populations of defined cells that secrete hundreds of all-natural factors. Our technology captures these powerful multi-active biologics to produce an investigational therapy called IMM01-STEM.
IMM01-STEM represents the balanced set of factors that typically diminish with age. Our therapeutic has the potential to eliminate the effects of age and immune-related diseases by replenishing these critical components that maintain optimal cell and immune responses.
